Pascal Marchand

1.3k total citations
67 papers, 1.1k citations indexed

About

Pascal Marchand is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Pascal Marchand has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Organic Chemistry, 20 papers in Molecular Biology and 8 papers in Toxicology. Recurrent topics in Pascal Marchand's work include Synthesis and Biological Evaluation (21 papers), Synthesis and biological activity (20 papers) and Synthesis and Reactivity of Heterocycles (11 papers). Pascal Marchand is often cited by papers focused on Synthesis and Biological Evaluation (21 papers), Synthesis and biological activity (20 papers) and Synthesis and Reactivity of Heterocycles (11 papers). Pascal Marchand collaborates with scholars based in France, Brazil and Germany. Pascal Marchand's co-authors include Guillaume Le Baut, Marc Le Borgne, Marc‐Antoine Bazin, Rolf W. Hartmann, Marie‐Renée Nourrisson, Patrice Le Pape, Muriel Duflos, Laurent Meijer, Thierry Besson and Nadège Loaëc and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Pharmacology and Experimental Therapeutics and Applied Microbiology and Biotechnology.

In The Last Decade

Pascal Marchand

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Marchand France 19 731 305 104 92 92 67 1.1k
Guillaume Le Baut France 18 612 0.8× 280 0.9× 165 1.6× 101 1.1× 55 0.6× 77 1.0k
Halmuthur M. Sampath Kumar India 18 680 0.9× 506 1.7× 75 0.7× 66 0.7× 45 0.5× 43 1.1k
Liqiao Shi China 19 398 0.5× 287 0.9× 41 0.4× 117 1.3× 27 0.3× 46 844
Baljinder Singh India 18 272 0.4× 341 1.1× 36 0.3× 128 1.4× 118 1.3× 61 965
Louise Domeneghini Chiaradia Brazil 18 536 0.7× 342 1.1× 16 0.2× 89 1.0× 61 0.7× 20 878
Bogdan A. Šolaja Serbia 22 798 1.1× 383 1.3× 74 0.7× 55 0.6× 452 4.9× 77 1.4k
Muriel Duflos France 15 501 0.7× 202 0.7× 73 0.7× 96 1.0× 12 0.1× 48 732
Rajeev Kharb India 14 665 0.9× 360 1.2× 34 0.3× 57 0.6× 24 0.3× 30 1.1k
Christoph Reiter Germany 15 357 0.5× 380 1.2× 28 0.3× 45 0.5× 240 2.6× 16 989
Renáta Minorics Hungary 19 377 0.5× 438 1.4× 212 2.0× 68 0.7× 30 0.3× 57 823

Countries citing papers authored by Pascal Marchand

Since Specialization
Citations

This map shows the geographic impact of Pascal Marchand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Marchand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Marchand more than expected).

Fields of papers citing papers by Pascal Marchand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Marchand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Marchand. The network helps show where Pascal Marchand may publish in the future.

Co-authorship network of co-authors of Pascal Marchand

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Marchand. A scholar is included among the top collaborators of Pascal Marchand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Marchand. Pascal Marchand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Araújo, Rodrigo Santos Aquino de, Michel Leandro de Campos, Roberto Pontarolo, et al.. (2025). 2-Aminothiophene Derivatives—New Drug Candidates Against Leishmaniasis: Drug Design, Synthesis, Pharmacomodulation, and Antileishmanial Activity. Pharmaceuticals. 18(1). 125–125. 3 indexed citations
2.
Marchand, Pascal, et al.. (2024). Biological properties and in silico studies of thiazolopyrimidine derivatives active against visceral and cutaneous Leishmania spp. amastigote forms. SHILAP Revista de lepidopterología. 12. 100228–100228. 1 indexed citations
3.
Primas, Nicolas, Caroline Castera‐Ducros, Christophe Curti, et al.. (2024). 31st Annual GP2A Medicinal Chemistry Conference. SHILAP Revista de lepidopterología. 3(1). 209–243.
4.
Khemakhem, Bassem, et al.. (2023). New Specific α‐Glucosidase Inhibitor Flavonoid from Thymelaea tartonraira Leaves: Structure Elucidation, Biological and Molecular Docking Studies. Chemistry & Biodiversity. 20(3). e202200944–e202200944. 13 indexed citations
5.
Lima-Neto, Reginaldo Gonçalves de, Rejane Pereira Neves, Cláudia Ferraz, et al.. (2023). Antifungal Efficacy of Imidazo[1,2- a ]Pyrazine-Based Thiosemicarbazones and Thiazolidinediones Against Sporothrix Species. Future Microbiology. 18(17). 1225–1233. 2 indexed citations
6.
Ourliac‐Garnier, Isabelle, Cédric Logé, Florence O. McCarthy, et al.. (2021). Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases. Molecules. 26(21). 6572–6572. 3 indexed citations
7.
Nourrisson, Marie‐Renée, et al.. (2020). Microwave-Assisted Synthesis of Potential Bioactive Benzo-, Pyrido- or Pyrazino-thieno[3,2-d]pyrimidin-4-amine Analogs of MPC-6827. Pharmaceuticals. 13(9). 202–202. 10 indexed citations
8.
Bazin, Marc‐Antoine, Sandrine Cojean, Fabrice Pagniez, et al.. (2020). In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition. European Journal of Medicinal Chemistry. 210. 112956–112956. 16 indexed citations
9.
Brondani, Dalci José, Antônio Rodolfo de Faria, Julianna Ferreira Cavalcanti de Albuquerque, et al.. (2019). Biological Evaluation of Arylsemicarbazone Derivatives as Potential Anticancer Agents. Pharmaceuticals. 12(4). 169–169. 9 indexed citations
10.
Pitta, Maíra Galdino da Rocha, Moacyr Jesus Barreto de Melo Rêgo, Lucindo José Quintans‐Júnior, et al.. (2019). Design, synthesis and pharmacological evaluation of CVIB, a codrug of carvacrol and ibuprofen as a novel anti-inflammatory agent. International Immunopharmacology. 76. 105856–105856. 18 indexed citations
11.
Robert, Thomas, et al.. (2018). Synthesis and anticancer activity of novel bisindolylhydroxymaleimide derivatives with potent GSK-3 kinase inhibition. Bioorganic & Medicinal Chemistry. 26(14). 4209–4224. 15 indexed citations
12.
Marchand, Pascal, Marc‐Antoine Bazin, Fabrice Pagniez, et al.. (2015). Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines. European Journal of Medicinal Chemistry. 103. 381–395. 24 indexed citations
13.
Logé, Cédric, Marc Le Borgne, Babette Aicher, et al.. (2014). Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells. Bioorganic & Medicinal Chemistry Letters. 24(16). 3748–3752. 8 indexed citations
14.
Marchand, Pascal, Marie‐Renée Nourrisson, Cédric Logé, et al.. (2014). Synthesis and molecular modelling studies of 8-arylpyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4-amines as multitarget Ser/Thr kinases inhibitors. European Journal of Medicinal Chemistry. 92. 124–134. 47 indexed citations
15.
Marchand, Pascal, Marie‐Renée Nourrisson, Muriel Duflos, et al.. (2012). Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors. European Journal of Medicinal Chemistry. 58. 171–183. 50 indexed citations
16.
Giraud, F, et al.. (2010). Synthesis of N-aryl-3-(indol-3-yl)propanamides and their immunosuppressive activities. Bioorganic & Medicinal Chemistry Letters. 20(17). 5203–5206. 7 indexed citations
17.
Borgne, Marc Le, et al.. (2007). Synthesis and biological evaluation of 3-(azolylmethyl)-1H-indoles and 3-(α-azolylbenzyl)-1H-indoles as selective aromatase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 22(5). 667–676. 7 indexed citations
18.
Marchand, Pascal, et al.. (2003). Preparation and pharmacological profile of 7-(α-Azolylbenzyl)-1H-indoles and indolines as new aromatase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(9). 1553–1555. 28 indexed citations
19.
Marchand, Pascal, et al.. (2001). 強力鎮痛薬としての(インドール‐3‐イル)アルキルアミド類の合成と薬理学的評価. 51(10). 814–824. 1 indexed citations
20.
Borgne, Marc Le, et al.. (1999). New selective nonsteroidal aromatase inhibitors: Synthesis and inhibitory activity of 2,3 or 5-(α-azolylbenzyl)-1H-indoles. Bioorganic & Medicinal Chemistry Letters. 9(3). 333–336. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026